Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Palliative Care
•
Critical Care
•
Hospital Medicine
Do you prefer scopolamine patches, glycopyrrolate, or other treatment regimens to manage oral secretions at the end of life?
Related Questions
When do you recommend starting a continuous opioid infusion for symptom control at the end of life?
At what point should you consider deactivating ICDs or implanted pacemakers in patients nearing the end of life but not imminently dying?
What do you think about starting octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?
How do you counsel patients on the prognosis of advanced cancer as a generalist who is not highly specialized in cancer literature or cancer-directed therapies?
How do you decide whether to use lung POCUS versus CT as the next step when a chest X-ray is equivocal for pneumonia?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
Should long-acting subcutaneous insulin be started upfront in addition to regular insulin infusion for patients with diabetic ketoacidosis?
What is your approach to electrolyte repletion for patients hospitalized with non-cardiac conditions?
How do you think about deferring VTE prophylaxis versus implementing pharmacologic methods when chemical prophylaxis is contraindicated?
